Skip to main content
HairCited

Micro-aiguilles pour Alopecia Areata

A

Basé sur 32 études (1 meta-analysis, 9 RCTs) avec 1,908 participants au total. 25/32 études montrent des effets positifs.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dmicroneedling\u0026condition\u003Dalopecia\u002Dareata'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

En conclusion

Microneedling has strong evidence for supporting hair regrowth in alopecia areata, especially when combined with topical medications, and is backed by multiple randomized controlled trials.

  • 25 out of 32 studies show positive effects, with 9 RCTs providing robust evidence
  • Works by creating micro-injuries that stimulate healing responses and improve drug absorption
  • Most effective when combined with topical agents like corticosteroids or vitamin D3
  • Both professional clinical procedures and at-home derma rollers have been studied

Key Study Findings

scoping_review n=16
A Scoping Review of Exosome Delivery Applications in Hair Loss.
Dose: variable; exosomes predominantly from mesenchymal stem cells (MSCs) vs: Placebo Effet: None None
retrospective cohort n=7 Open-label
Combination Therapy With CGF and Microneedling-Assisted Compound Betamethasone for Resistant Alopecia Areata: A Pilot Study.
Dose: Concentrated growth factor (CGF) combined with microneedling-assisted compound betamethasone; multip vs: Placebo Effet: 85.7% achieved complete recovery; 14.3% achieved >50% regrowth; significant SALT score improvement None
randomized controlled trial n=24 18 weeks Open-label
A Comparative Clinical and Trichoscopic Study Between Fractional Radiofrequency Microneedling Versus Intralesional Steroids in Treatment …
Dose: Fractional radiofrequency microneedling (FRM), 6 sessions with 3-week intervals vs: Placebo Effet: Comparable efficacy between FRM and ILCS; nonsignificant differences in trichoscopic scores, PGA, an None
review
The role of microtrauma in hair regrowth and regeneration in non-scarring alopecia.
Dose: Various microtrauma procedures: microneedling, fractional/non-fractional lasers, contact immunothera vs: Placebo Effet: Positive outcomes reported for hair density and thickness with microneedling, lasers, LLLT, and PRP None
animal study 2 weeks
Investigating the potential mechanism of microneedling in alopecia areata mice based on 16S rRNA sequencing …
Dose: Halometasone topical applied every 2 days for 2 weeks after hand-held dermal microneedling treatment vs: Placebo Effet: Microneedling enhanced hair growth; restored gut microbiome diversity; reduced acetic acid and propa None

Key Statistics

34

Études

1908

Participants

Positive

A

Note

Referenced Papers

The Journal of … 2024 2 citations
Dermatology and therapy 2022 43 citations
Journal of the … 2020 10 citations
Proceedings (Baylor University. … 2020 8 citations
Journal of the … 2018 114 citations

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Posologies couramment utilisées

hairloss:
1.5 mm depth, weekly sessions

Limite supérieure : Not applicable

Posologies étudiées dans la recherche

Posologie Durée Effet N
variable; exosomes predominantly from mesenchymal stem cells (MSCs) -- Positive 16
Concentrated growth factor (CGF) combined with microneedling-assisted compound betamethasone; multip -- Positive 7
None -- Mixed --
Fractional radiofrequency microneedling (FRM), 6 sessions with 3-week intervals 18 weeks Neutral 24
Various microtrauma procedures: microneedling, fractional/non-fractional lasers, contact immunothera -- Positive --
Halometasone topical applied every 2 days for 2 weeks after hand-held dermal microneedling treatment 2 weeks Positive --
Microinfusion of medications into the skin (MMP) using tattoo devices; various drugs (minoxidil, ste -- Positive --
Melatonin 3 mg/kg; PBM diode laser 660nm, 100mW, 3 J/point, 2 sessions/week 12 weeks Mixed 60

Moment optimal de prise : Weekly sessions; avoid minoxidil for 24 hours post-treatment

Safety & Side Effects

Effets indésirables signalés

  • Scalp redness and inflammation (24-72 hours)
  • Mild bleeding at treatment site
  • Scalp tenderness and soreness
  • Rare: infection if proper sterilization not maintained

Interactions connues

  • Topical minoxidil (enhanced absorption; wait 24 hours after microneedling to apply)
  • Blood thinners (may increase bleeding during procedure)
  • Topical retinoids (discontinue 3-5 days before treatment)

Apport maximal tolérable : Not applicable

Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.

Frequently Asked Questions

Does Micro-aiguilles help with Alopecia Areata?
Based on 34 studies with 1,908 participants, there is strong evidence from multiple clinical trials that Micro-aiguilles may support Alopecia Areata management. Our evidence grade is A (Strong Evidence).
How much Micro-aiguilles should I take for Alopecia Areata?
Studies have used various dosages. A commonly studied range is 1.5 mm depth, weekly sessions. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Micro-aiguilles?
Reported side effects may include Scalp redness and inflammation (24-72 hours), Mild bleeding at treatment site, Scalp tenderness and soreness, Rare: infection if proper sterilization not maintained. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Micro-aiguilles and Alopecia Areata?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 34 peer-reviewed studies with 1,908 total participants. The overall direction of effect is positive.

Related Evidence

Micro-aiguilles pour d'autres pathologies

Avertissement FDA: Ces déclarations n'ont pas été évaluées par la Food and Drug Administration. Les produits et informations sur ce site ne sont pas destinés à diagnostiquer, traiter, guérir ou prévenir quelque maladie que ce soit. Les notes de preuve présentées sont basées sur notre analyse de la recherche publiée et évaluée par des pairs et ne constituent pas un avis médical. Consultez toujours votre professionnel de santé avant de commencer tout régime de compléments alimentaires.